News

AdCare Rhode Island Welcomes New Executive Director Amid Expansion

AdCare Rhode Island Welcomes New Executive Director Amid Expansion

AdCare Rhode Island Welcomes Nicole Paliotti as Executive Director

AdCare Rhode Island has announced the appointment of Nicole Paliotti as its new Executive Director. She is recognized for her dedication to healthcare services in the community, bringing years of experience in operations, project management, and addiction recovery to the facility. Nicole’s appointment comes at a crucial time as the organization is on the brink of completing an extensive facility expansion.

Expansion Underway at AdCare Rhode Island

The major expansion and remodeling of AdCare Rhode Island follow a fire that occurred in April 2021. The updated facility aims to accommodate more individuals and families requiring addiction treatment services. Nicole Paliotti expressed her excitement about leading AdCare Rhode Island through this transformative period, emphasizing the organization’s commitment to serving the community efficiently.

Investing in Recovery Support

Nicole’s passion for supporting those struggling with addiction stems from her personal journey to recovery. She articulated, "This is such an exciting time, as we are very close to completing our new building and upgrades. We are also dedicated to becoming a certified recovery-friendly workplace. This achievement reinforces our commitment to providing the best care for our patients. We strive to set the highest standard in supporting their recovery journeys."

A Strong Background in Addiction Treatment

Before joining AdCare, Paliotti was the Clinical Outreach Manager for Aware Recovery Care, a pioneering program that focuses on providing in-home treatment for substance use disorders. Her previous experience also includes working as a Project Management Consultant for the Rhode Island Department of Health, where she led various healthcare initiatives. Nicole holds an MBA from Johnson & Wales University and a Master’s in Healthcare Administration from Salve Regina University.

Leadership's Vision for the Future

Tyler Harrell, SVP of Operations at American Addiction Centers, the parent company of AdCare Rhode Island, praised Nicole’s appointment, stating, "We are thrilled to have a leader like Nicole take the helm at AdCare Rhode Island. Her blend of knowledge in addiction treatment and compassion for our patients enhances our mission to support recovery effectively." He further pointed out the exciting developments taking place at AdCare, highlighting their intentions to elevate standards in addiction treatment throughout New England.

Comprehensive Care at AdCare Rhode Island

AdCare Rhode Island is part of the American Addiction Centers and provides a broad range of services designed to support individuals battling drug and alcohol addiction as well as co-occurring mental health disorders. Their offerings include medical detoxification, residential care, and outpatient therapy, ensuring a continuum of care is available for those in need.

Contact Information for Inquiries

For more information about the services at AdCare Rhode Island or to inquire about leadership and program developments, contact Amanda Lautieri, Brand & Communications Manager at ALautieri@ContactAAC.com.

Frequently Asked Questions

What is the role of the new Executive Director at AdCare Rhode Island?

The new Executive Director, Nicole Paliotti, will lead the organization through an important expansion of its facility and services while ensuring high standards of care for patients.

How is AdCare Rhode Island expanding its facilities?

After recovering from a fire in 2021, AdCare Rhode Island is nearing the completion of a major remodel that will allow them to serve more individuals and families needing addiction support.

What kind of services does AdCare Rhode Island provide?

AdCare Rhode Island offers a full continuum of care, including medical detox, residential treatment, and outpatient therapy for individuals dealing with substance use and mental health issues.

What qualifications does Nicole Paliotti bring to her new role?

Nicole has significant experience in healthcare operations, project management, and addiction treatment, along with advanced degrees in business and healthcare administration.

Who can be contacted for more information about AdCare Rhode Island?

Amanda Lautieri, the Brand & Communications Manager, can be contacted for further inquiries at ALautieri@ContactAAC.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 169

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 133

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 563

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 555

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 404

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 207

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 164

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 315

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 61

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Interoperability: The Free Partner Edition by interop.io

Updated Category News Views 230

Unlocking New Potential in Fintech with Free Edition interop.io, known as a frontrunner in desktop interoperability, is set to revolutionize the way fintech companies operate with the introduction of a cost-free edition of their software suite, named io.Connect. This new initiative aims to provide fintechs, regardless of their size or stage, with the opportunity to adopt...

Continue Reading
Massage Envy Celebrates Scholarship Winners and Their Future

Updated Category News Views 164

Massage Envy Celebrates Scholarship Winners Eight outstanding individuals have been recognized as winners of the Massage Envy National Scholarship Sweepstakes, each receiving a $2,500 scholarship to support their journey into the massage therapy profession. This initiative demonstrates Massage Envy's commitment to fostering the next generation of talented massage...

Continue Reading
Paul Mueller Company Updates Investors on Dividend Plans

Updated Category News Views 397

Paul Mueller Company Declares Cash Dividend Paul Mueller Company (OTC: MUEL) has some exciting news for its investors. The company has recently announced that its Board of Directors has declared a cash dividend of $0.30 per share on its outstanding common stock. This dividend reflects the company’s ongoing commitment to providing value to its shareholders. Details of...

Continue Reading
Photocure Enhances Leadership with Jane Healy as GM EMEA

Updated Category News Views 360

Photocure Welcomes Jane Healy as Vice President and General Manager EMEA Photocure ASA (OSE: PHO), known as the Bladder Cancer Company, has made a significant move by appointing Jane Healy as the new Vice President and General Manager for the EMEA region. This strategic decision underscores Photocure's commitment to enhancing its leadership in the uro-oncology sector....

Continue Reading
TDS Hits Bumps but Keeps Shareholders Happy

Updated Category News Views 48

High Hopes and Hard Hits: TDS in 2026 Listen up, folks. Telephone and Data Systems, Inc. (NYSE: TDS) just popped the hood on their third quarter earnings, and it's a mixed bag with plenty to chew over. Operating revenues are slightly down from last year, but management's got some tricks up their sleeves. CEO Walter Carlson is trumpeting their expanded fiber service...

Continue Reading